Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
maintenance phase is the heavy draw 26 weeks 13 vials Standard Phase 2 duration 32 weeks 16 vials Phase 2 T2D study duration 68 weeks 30 vials REDEFINE 1 / REDEFINE 2 endpoint duration Peptide Vials (10 mg vial, 2.4 mg/week target) Each 10 mg vial covers about 4 weekly doses at 2.4 mg/week
The results will give the per-component concentration in the reconstituted solution
And in the trials, that shows up: retatrutide landed around 24 percent body-weight loss, tirzepatide around 21 percent
Growth hormone release peaks during deep sleep
Take-home options are available
US$ 28.00
US$ 28.34
US$ 21.46
US$ 25.33
US$ 20.15
US$ 28.26
